Clinical Trials Logo

Syndrome clinical trials

View clinical trials related to Syndrome.

Filter by:

NCT ID: NCT05972317 Recruiting - Clinical trials for Irritable Bowel Syndrome

The Stool Microbiome of Treated and Untreated IBS (Irritable Bowel Syndrome) Patients

Start date: April 10, 2024
Phase: N/A
Study type: Interventional

Irritable bowel syndrome (IBS) is considered the most common gastrointestinal disorder in humans, with an estimated global prevalence of 11%-20% of all humans. Alterations in the gut microbiome are at the center of IBS, and microbiome-induced volatile metabolites in response to dietary exposures is believed to drive a downstream impact on susceptible hosts, thereby driving the disease. However, the characteristics and functions of these metabolites remain unknown to date. The two main mechanisms invoking IBS development and flares include 1) an increase in luminal water content due to malabsorption of small molecules and 2) incrementation of colon gas production generated by the fermentation of small molecules by gut bacteria.Yet to date, a person-specific elucidation of the specific small molecules and bacteria driving IBS, and their downstream effects on the human gut epithelium remain unknown. Over the past years, it became evident that dietary regimes, and their interactions with the intestinal microbiome, are at the center of IBS symptom generation and alleviation. The most widely used dietary intervention is a highly restrictive diet, the low-Fermentable Oligo-saccharides Di-saccharides Mono-saccharides And Polyols (FODMAP) diet, based on avoidance of multiple food items that contain available fermentable molecules. The low-FODMAP diet remains an effective line of treatment for IBS patients, yet due to its complexity and unhealthy nature, it remains a last line of treatment and fails to impact the majority of IBS patients.

NCT ID: NCT05971966 Recruiting - Clinical trials for Patellofemoral Pain Syndrome

Effects of Virtual Reality Rehabilitation and Muscle Energy Technique in Patients With Patellofemoral Pain Syndrome.

Start date: August 30, 2023
Phase: N/A
Study type: Interventional

The aim of this randomized controlled trial is to determine the effects of Virtual reality rehabilitation and muscle energy techniques in patients with patellofemoral pain syndrome for reducing pain, enhancing knee range of motion and improve functional activities.

NCT ID: NCT05971524 Recruiting - Diabetes Mellitus Clinical Trials

Effect of Oral 6-bromotryptophan on Safety, Pharmacokinetics and Efficacy in Metabolic Syndrome Individuals

BROMO
Start date: May 4, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

Safety, pharmacokinetics and efficacy of a novel endogenous plasma metabolite, 6-bromotryptophan, will be established in metabolic syndrome/ insulin resistant participants.

NCT ID: NCT05970445 Active, not recruiting - Hearing Loss Clinical Trials

Clinical Phenotypic Characteristics of SC26A4

Start date: May 15, 2023
Phase:
Study type: Observational

The presence or absence of SC26A4, whether combined with Mondini malformation, and patient age, are important factors affecting the degree of hearing loss in the Chinese population.

NCT ID: NCT05970146 Recruiting - Clinical trials for Complex Regional Pain Syndromes

Cervical Epidural and Stellate Ganglion Block in Upper Limb Complex Regional Pain Syndrome

Start date: August 1, 2023
Phase: Phase 4
Study type: Interventional

Evaluate the efficacy of two regimens of management in relieving chronic refractory pain in patients with upper limb complex regional pain syndrome after orthopedic trauma

NCT ID: NCT05969873 Completed - Down Syndrome Clinical Trials

Effect Of Pilates On Postural Control And Balance In Children With Down's Syndrome

Start date: July 16, 2023
Phase: N/A
Study type: Interventional

Down's syndrome (DS) is a genetic condition characterized by the presence of an extra chromosome 21, leading to various clinical symptoms. Individuals with DS often experience challenges in balance, posture, and motor skills, which can impact their daily activities. Pilates activities focus on the concept of control of muscles. Pilates increases trunk flexibility, abdominal and core strength and endurance, and deep core muscle activation hence improving balance and posture.

NCT ID: NCT05969821 Not yet recruiting - Lymphoma Clinical Trials

Clonal Hematopoiesis of Immunological Significance

CHIS
Start date: September 2023
Phase:
Study type: Observational [Patient Registry]

Ambispective, national, multicenter observational cohort study aimed at characterizing the satellite dysimmune manifestations of clonal hematopoiesis, including Vexas (Vacuoles, E1 enzyme, X-linked, Autoinflammatory and Somatic) syndrome.

NCT ID: NCT05969093 Recruiting - Clinical trials for Carpal Tunnel Syndrome

Refining the Interpretation of the Tinel's Sign for Carpal Tunnel Syndrome

Start date: July 29, 2023
Phase:
Study type: Observational

This is an observational study to investigate the electromyographic (EMG) activity and nerve conduction velocity (NCV) of healthy individuals during the Tinel's Sign performed at different wrist positions. The study aims to identify the wrist position that best isolates median nerve activity during the Tinel's Sign.

NCT ID: NCT05967858 Completed - Starvation Clinical Trials

Incidence of Refeeding Syndrome in Consecutively Admitted Patients

Start date: December 1, 2013
Phase:
Study type: Observational

The incidence and main risk-factors analyzed in consecutive in-patients in the departments og gastroenterology and ear-nose and throat diseases (cancer in radiation therapy)

NCT ID: NCT05967494 Not yet recruiting - Clinical trials for Chronic Fatigue Syndrome

Discovering Trends in Chronic Fatigue Syndrome Patients' Clinical Study Experiences

Start date: August 2024
Phase:
Study type: Observational

The study seeks to delve into the firsthand experiences of patients diagnosed with chronic fatigue syndrome who partake in a separate clinical trial featuring a specific medical intervention. The primary emphasis will be on meticulously tracking the rates of trial completion and withdrawal among these individuals. The data collected from this study will help improve future outcomes for all chronic fatigue syndrome patients as well as those in under-represented demographic groups.